in this double-blind , randomized , multicenter trial , an oral dosing regimen of 500 mg twice daily ( bid ) of cephradine was evaluated for the treatment of acute uncomplicated urinary tract infections due to susceptible pathogens .
C0007738
cephradine
C0042029
of